K
Kymera Therapeutics, Inc. (KYMR)
NGM – Real vaqt narxi. Valyuta: USD
83.55
-0.55 (-0.65%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
83.55
-0.55 (-0.65%)
Yopilishda: May 12, 2026, 4:00 PM EDT
This stock has a consensus price target of $98.75 based on the ratings of 33 analysts. The high is $140.00 and the low is $37.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 37 | $ 98.75 | $ 140 |
| O’zgarish | -57.02% | 14.72% | 62.64% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-06 | 23.14% | Canaccord Genuity | $106 | Initiates Coverage On | Buy |
| 2026-03-16 | 27.79% | Jefferies | $122 → $110 | Assumes | Buy |
| 2026-03-03 | 48.7% | UBS | $90 → $128 | Maintains | Buy |
| 2026-03-02 | 39.41% | Citigroup | $110 → $120 | Maintains | Buy |
| 2026-03-02 | 16.17% | Stephens & Co. | $95 → $100 | Maintains | Overweight |